Affiliates Work - Alnylam grants RNAx license to key patent in RNA interference.(German affiliate of Alnylam Pharmaceuticals, Inc., Ribopharma AG, grants RNAx GmbH license): An article from: BIOTECH Patent News

	List Price: $5.95 Our Price: $5.95 Availability: Available for download now Manufacturer: Biotech Patent News
Average Customer Rating: [ not yet rated ]
Binding: Digital Format: HTML Label: Biotech Patent News Manufacturer: Biotech Patent News Number Of Pages: 3 Publication Date: 2004-02-01 Publisher: Biotech Patent News Release Date: 2005-07-31 Studio: Biotech Patent News
Editorial Reviews: This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2004. The length of the article is 603 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Alnylam grants RNAx license to key patent in RNA interference.(German affiliate of Alnylam Pharmaceuticals, Inc., Ribopharma AG, grants RNAx GmbH license) Publication: BIOTECH Patent News (Newsletter) Date: February 1, 2004 Publisher: Biotech Patent News Volume: 18 Issue: 2 Distributed by Thomson Gale